Market Overview

Adaptimmune Therapeutics PLC (NYSE: ADAP)

7.84 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/06/20SVB LeerinkMaintainsMarket Perform10.0
6/01/20MizuhoMaintainsNeutral9.0
4/27/20CitigroupMaintainsBuy5.0
4/22/20MizuhoInitiates Coverage OnNeutral3.0
8/02/19GuggenheimDowngradesNeutral
5/31/19Roth CapitalInitiates Coverage OnBuy7.0
5/30/19CitiAssumesBuy8.0
5/07/19SVB LeerinkDowngradesMarket Perform
10/22/18Raymond JamesMaintainsOutperform16.0
3/17/17Wells FargoInitiates Coverage OnMarket Perform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter